In 2018, Qiagen N.V. ( QGEN - Free Report ) — a global player in the niche space — received the FDA approval to expand the usage of EGFR test in lung cancer. A Plethora of Regulatory Approvals Favorable tidings on the regulatory front have always favored Intuitive Surgical. Of the latest ones, the company submitted 510(k) for the second indication of TransOral Robotic Surgery. It is also working through supply chain optimization as Intuitive Surgical begins to ramp up production for SP.